eMultipleSclerosis Review
Treatment Considerations for Aging Patients
March 08, 2022
As people with MS age, how does their response to their long-term DMT change? Is there a time when disease-modifying therapy can be safely discontinued? In which patients? At what age? What role do comorbidities play in making these decisions?
New York
EMultipleSclerosis Review podcast channel
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast